Membrane proteins and virus virulence.
D000818:Animals; D001921:Brain / Q000378:metabolism; D003588:Cytopathogenic Effect, Viral; D006023:Glycoproteins / Q000037:antagonists & inhibitors / Q000276:immunology / Q000378:metabolism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008081:Liposomes / Q000378:metabolism; D008459:Measles virus / Q000378:metabolism / Q000472:pathogenicity; D009842:Oligopeptides / Q000494:pharmacology; D010252:Paramyxoviridae / Q000276:immunology / Q000378:metabolism / Q000472:pathogenicity*; D010447:Peptide Hydrolases / Q000378:metabolism; D010253:Respirovirus Infections / Q000276:immunology / Q000378:metabolism / Q000382:microbiology; D013344:Subacute Sclerosing Panencephalitis / Q000378:metabolism / Q000382:microbiology; D014759:Viral Envelope Proteins / Q000037:antagonists & inhibitors / Q000276:immunology / Q000378:metabolism; D014760:Viral Fusion Proteins; D014763:Viral Matrix Proteins; D014764:Viral Proteins / Q000037:antagonists & inhibitors / Q000276:immunology / Q000378:metabolism*; D014771:Virion / Q000378:metabolism / Q000472:pathogenicity; D014774:Virulence; D014779:Virus Replication / Q000187:drug effects
D006023:Glycoproteins; D008081:Liposomes; D009842:Oligopeptides; D014759:Viral Envelope Proteins; D014760:Viral Fusion Proteins; D014763:Viral Matrix Proteins; D014764:Viral Proteins; D010447:Peptide Hydrolases